Form PREC14A - Preliminary proxy statements, contested solicitations:
SEC Accession No. 0001213900-26-059144
Filing Date
2026-05-19
Accepted
2026-05-19 17:25:34
Documents
28

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT ea0291346-01.htm   iXBRL PREC14A 2041976
6 GRAPHIC tbarchart_001.jpg GRAPHIC 278719
7 GRAPHIC tbarchart_002.jpg GRAPHIC 281337
8 GRAPHIC tcampaign_logo.jpg GRAPHIC 51910
9 GRAPHIC tdavid.jpg GRAPHIC 94335
10 GRAPHIC telaine.jpg GRAPHIC 91215
11 GRAPHIC tjames_001.jpg GRAPHIC 69040
12 GRAPHIC tkevin.jpg GRAPHIC 83955
13 GRAPHIC tmark.jpg GRAPHIC 54077
14 GRAPHIC tproxy_001.jpg GRAPHIC 1225662
15 GRAPHIC tproxy_002.jpg GRAPHIC 1238180
16 GRAPHIC tsteven.jpg GRAPHIC 79263
17 GRAPHIC tvaxart_logo.jpg GRAPHIC 37558
  Complete submission text file 0001213900-26-059144.txt   11494698

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE vxrt-20260519.xsd EX-101.SCH 12522
3 XBRL DEFINITION FILE vxrt-20260519_def.xml EX-101.DEF 7217
4 XBRL LABEL FILE vxrt-20260519_lab.xml EX-101.LAB 40701
5 XBRL PRESENTATION FILE vxrt-20260519_pre.xml EX-101.PRE 12898
31 EXTRACTED XBRL INSTANCE DOCUMENT ea0291346-01_htm.xml XML 213896
Mailing Address 310 UTAH AVENUE, SUITE 150 SOUTH SAN FRANCISCO CA
Business Address 310 UTAH AVENUE, SUITE 150 SOUTH SAN FRANCISCO CA (650) 550-3500
Vaxart, Inc. (Filed by) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREC14A
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 310 UTAH AVENUE, SUITE 150 SOUTH SAN FRANCISCO CA
Business Address 310 UTAH AVENUE, SUITE 150 SOUTH SAN FRANCISCO CA (650) 550-3500
Vaxart, Inc. (Subject) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREC14A | Act: 34 | File No.: 001-35285 | Film No.: 261000414
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)